Reconsidering early HIV treatment and supervised treatment interruptions.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 15578109.
- Also identified by PMC identifier 529427.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Another study casts doubt on the value of early treatment and treatment interruptions. What are the implications of this study for our understanding of HIV pathogenesis, treatment, and vaccine development?
Medical subject headings
- Anti-Retroviral Agents
- HIV Infections